FDA Recalls List – August 25, 2011
This article was originally published in The Tan Sheet
You may also be interested in...
“There’s a heightened need for products that deliver against health, hygiene and clean home concerns and a willingness to spend just a little bit more to ensure that I’m using a product that I know and trust,” says CFO Jon Moeller
Curon thinks tenalisib can offer a differentiated and safe new therapy for hematologic cancers such as multiple forms of lymphoma. Axis and PharmaEssentia team up on TCR therapy R&D in Taiwan.
The COVID-19 pandemic continues to drive innovation in robotics to provide care and comfort at a safe distance.